| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/02/2000 | EP0975657A1 Method of purifying protein from inclusion bodies |
| 02/02/2000 | EP0975655A1 Improvements in adaptor-based sequence analysis |
| 02/02/2000 | EP0975654A1 Composition and method for treatment of cmv infections |
| 02/02/2000 | EP0975653A1 Recombination of polynucleotide sequences using random or defined primers |
| 02/02/2000 | EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 02/02/2000 | EP0975650A1 Oligomers which inhibit expression of collagen genes |
| 02/02/2000 | EP0975649A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies |
| 02/02/2000 | EP0975427A1 A device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device |
| 02/02/2000 | EP0975371A1 Antisense oligonucleotide compositions and methods for the modulation of activating protein 1 |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975355A2 Hexameric fusion proteins and uses therefor |
| 02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
| 02/02/2000 | EP0975332A1 Improved methods of delivery using cationic lipids and helper lipids |
| 02/02/2000 | EP0866859A4 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 02/02/2000 | EP0866855A4 Method of producing alpha 2,3-sialyltransferase |
| 02/02/2000 | EP0839205B1 Liver-specific adenovirus expression vector |
| 02/02/2000 | EP0775210B1 Mutated penicillin g acylase genes |
| 02/02/2000 | EP0752472B1 Gene originating in corynebacterium and use thereof |
| 02/02/2000 | EP0729580B1 Method of identifying hdm-2-specific antibodies |
| 02/02/2000 | EP0713532B1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/02/2000 | EP0713529B1 Growth differentiation factor of the TGF-B family |
| 02/02/2000 | EP0656117B1 A methodology for selecting superagonists, antagonists and superantagonists of interleukin 6 |
| 02/02/2000 | EP0539530B1 Purification directed cloning of peptides |
| 02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 02/02/2000 | CN1243545A Plant apple penicillin promoter sequences |
| 02/02/2000 | CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 02/02/2000 | CN1243543A Purification and/or concentration of DNA by cross-flow filtration, separation of endotoxins from nucleic acid preparation |
| 02/02/2000 | CN1243542A Method for purifying DNA in cross-flow centrifuge |
| 02/02/2000 | CN1243161A Nuclear polygon virogene engineering carrier for cysteine protease deficiency type domestic silkworms |
| 02/01/2000 | US6020540 Gene encoding endochitinase |
| 02/01/2000 | US6020539 Process for transforming Gramineae and the products thereof |
| 02/01/2000 | US6020538 Genetic transformation of orchids |
| 02/01/2000 | US6020537 Prion protein standard and method of making same |
| 02/01/2000 | US6020526 Amide-based cationic lipids |
| 02/01/2000 | US6020481 Fluorescent labeling reagents; dideoxy polynucleotide sequencing and fragment analysis methods. |
| 02/01/2000 | US6020478 Human tumor-associated antigen |
| 02/01/2000 | US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme |
| 02/01/2000 | US6020473 Nucleic acids encoding variants of vascular endothelial cell growth factor |
| 02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
| 02/01/2000 | US6020467 Antibodies against sulfotransferase |
| 02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
| 02/01/2000 | US6020465 Recombinant avian type i interferon |
| 02/01/2000 | US6020464 Isolated Smad protein |
| 02/01/2000 | US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| 02/01/2000 | US6020462 Nucleic acids encoding the hypoxia inducible factor-1 |
| 02/01/2000 | US6020461 Detection of gonorrhea is one area in which nucleic acid hybridization holds great potential as a diagnostic tool in clinical medicine. |
| 02/01/2000 | US6020318 DNA methyltransferase genomic sequences and antisense oligonucleotides |
| 02/01/2000 | US6020309 Pharmaceuticals based on papillomaviruses |
| 02/01/2000 | US6020306 Receptor-type tyrosine kinase and use thereof |
| 02/01/2000 | US6020202 Composition and methods for transfecting eukaryotic cells |
| 02/01/2000 | US6020199 Antisense modulation of PTEN expression |
| 02/01/2000 | US6020198 Antisense modulation of RIP-1 expression |
| 02/01/2000 | US6020197 Neuroblasts are dependant upon about 1 to 100 ng/ml of bfgf for long term maintenance. |
| 02/01/2000 | US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin. |
| 02/01/2000 | US6020191 Adenoviral vectors capable of facilitating increased persistence of transgene expression |
| 02/01/2000 | US6020190 Plant ubiquitin promoter system |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof |
| 02/01/2000 | US6020186 Device and process for isolating nucleic acids from cell suspensions |
| 02/01/2000 | US6020183 Analog of haemophilus Hin47 with reduced protease activity |
| 02/01/2000 | US6020182 Subunit respiratory syncytial virus vaccine preparation |
| 02/01/2000 | US6020180 C. antarctica lipase and lipase variants |
| 02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
| 02/01/2000 | US6020178 Transglutaminase and gene encoding same |
| 02/01/2000 | US6020177 Heptaprenyl diphosphate-synthetase |
| 02/01/2000 | US6020176 Converting copalyl pyrophosphate to ent-kaurene and are useful for the regulation of plant growth. |
| 02/01/2000 | US6020172 Nucleic acid delivery with ovine adenoviral vectors |
| 02/01/2000 | US6020171 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof |
| 02/01/2000 | US6020170 Method of preparing a monoclonal antibody |
| 02/01/2000 | US6020169 Production of secreted foreign polypeptides in plant cell culture |
| 02/01/2000 | US6020168 Porcine CNP gene and precursor protein |
| 02/01/2000 | US6020167 Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 02/01/2000 | US6020166 Nucleic acid encoding an altered telomere repeat binding factor 2 |
| 02/01/2000 | US6020165 Cytikine signal regulators |
| 02/01/2000 | US6020164 Human RNA binding proteins |
| 02/01/2000 | US6020163 Lipocalin homolog |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 02/01/2000 | US6020160 For the treatment of infection, particularly bacterial infections. |
| 02/01/2000 | US6020159 3-dehydroquinate synthase |
| 02/01/2000 | US6020158 Intracellular g-protein complex which mediates further intracellular signaling activities generally the production of second messengers such as cyclic amp (camp), phospholipase c, inositol triphosphate or ion channel proteins. |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020156 Method and system for biosynthesizing a desired biologically useful macromolecule in a chlorella cell and for controlling biosynthesis thereof |
| 02/01/2000 | US6020155 Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression |
| 02/01/2000 | US6020154 H. influenzae HxuB and HxuC genes, proteins and methods of use |
| 02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
| 02/01/2000 | US6020151 Process for the production of 7-ADCA via expandase activity on penicillin G |
| 02/01/2000 | US6020149 Combining a microbially required nucleotide phosphatase, a nucleoside phosphate and the substance to be tested, and assessing the extent of degradation of the nucleoside phosphate in the presence and absence of the substance |
| 02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
| 02/01/2000 | US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses. |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020141 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization |
| 02/01/2000 | US6020138 Methods for detecting nucleic acids by ligation of multiple oligomers |
| 02/01/2000 | US6020135 Monitoring expression of these genes is used to provide indications of p53 status in a cell. such monitoring can also be used to screen for useful anti-cancer therapeutics, as well as for substances which are carcinogenic. |
| 02/01/2000 | US6020134 Method for diagnosing cancer via DNA hybridization |
| 02/01/2000 | US6020133 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use |
| 02/01/2000 | US6020132 Chimeric nucleic acids compounds that have the capacity of forming triplex structures. |
| 02/01/2000 | US6020130 Nucleic acid ligands that bind to and inhibit DNA polymerases |